How would you treat a young man with refractory AML after HIDAC induction who developed cerebellar toxicity to HIDAC and previously received doxorubicin (300 mg/m2) for lymphoma?
What re-induction regimen without cytarabine or an anthracycline is likely to be most effective?
Answer from: Medical Oncologist at Academic Institution
CLAG-M (cladribine, Ara-C, mitoxantrone, with G-CSF priming)
Sign in or Register to read more